| Metric | Q4'25 | Q1'26 | Change |
|---|---|---|---|
| Revenue | $44.4B Q4 2025 (+8.7% YoY) | $44.7B Q1 2026 (+12.1% YoY) | +$300M sequential, accelerating growth |
| Adjusted EPS | -$1.19 Q4 2025 | $3.37 Q1 2026 | Massive seasonal swing, beat expectations by ~$0.50 |
| Medicaid HBR | 93.0% Q4 2025 | 93.1% Q1 2026 | +10 bps but 50 bps improvement vs Q1 2025 |
| Medicare HBR | ~86% Q4 2025 (implied) | 84.9% Q1 2026 | ~110 bps improvement, both MA and PDP beat |
| Marketplace HBR | Higher than expected Q4 | Slightly higher than expected Q1 | Consistent underperformance but offset by SG&A savings |
| Consolidated HBR | ~92% Q4 2025 (estimated) | 87.3% Q1 2026 | Significant seasonal improvement |
| Cash Flow from Operations | Not disclosed Q4 | $4.4B Q1 2026 | Strong quarter driven by PDP receivable sale |
| Debt-to-Cap Ratio | 46.5% Q4 2025 | 43.2% Q1 2026 | 330 bps deleveraging from debt paydown |
| Medicaid Members | 12.5M Q4 2025 | 12.4M Q1 2026 | Slight attrition continues as expected |
| ACA Members | ~5.0M Q4 2025 | 3.58M Q1 2026 | 28% decline post-APTC expiration, as guided |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.